Your browser doesn't support javascript.
loading
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.
Nahi, Hareth; Afram, Gabriel; Uttervall, Katarina; Lockmer, Sandra; Tätting, Love; Gahrton, Gösta; Kashif, Muhammad; Alici, Evren; Stromberg, Olga; Klimkowska, Monika; Lund, Johan.
Afiliação
  • Nahi H; Department of Medicine, Institution for biomedicine and clinical science, Linköping, Sweden.
  • Afram G; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Uttervall K; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Lockmer S; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Tätting L; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Gahrton G; Department of Medicine, Institution for biomedicine and clinical science, Linköping, Sweden.
  • Kashif M; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Alici E; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Stromberg O; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Klimkowska M; Department of Medicine, Stockholm, Sweden.
  • Lund J; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Cancer Med ; 12(22): 20736-20744, 2023 11.
Article em En | MEDLINE | ID: mdl-37921243

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article